Abstract:Objective:To synthesize novel platinum(II) complexes by the choices of the chiral centers in carrier groups and leaving groups,so as to improve the water solubility,and to find out the new platinum(II) complexes with good activities.Methods:(1R,2R)-N1-(pyridine-2-ylmethyl) cyclohexane-1,2-diamine(LR) and(1S,2S)-N1-(pyridine-2-ylmethyl) cyclohexane-1,2-diamine(LS) were designed and synthesized.The platinum(II) complexes were synthesized by using LR and LS as carrier ligands,and using chloride,sulfate,oxalate,malonate,1,4-butyldicarboxylate and 1,1-cyclobutyldicarboxylate anions as leaving groups.The in vitro cytotoxicity of the target compounds on human lung cancer A549,human colon cancer cell line HCT-116,human hepatoma cell line HepG2 and human breast cancer cell line MCF-7 were tested by MTT method.Results:Twelve platinum(II) complexes were synthesized and their structures were determined by elemental analysis,IR,1H-NMR and ESI-MS spectra.These platinum(II) complexes overcame the problem of poor water-solubility,and exhibited general activity to MCF-7 cell line.Conclusion:The target compounds are synthesized successfully by the choices of leaving groups and chiral centers in carrier ligands on the basis of structure of oxaliplatin.It can provide a guidance for the design of more reasonable oxaliplatin analogues containing chiral centers.

Synthesis and in Vitro Cytotoxicity of Novel Hydrophilic Chiral 2-Alkoxy-1,4-butanediamine Platinum (II) Complexes.

Synthesis, characterization, and cytotoxicity of new types of binuclear platinum(II) complexes

Synthesis, characterization and cytotoxicity of iodo-bridged binuclear platinum(II) complexes.

Synthesis and in Vitro Cytotoxicity of Platinum(Ii) Complexes with Chiral N-Monosubstituted 1,2-Cyclohexyldiamine Derivatives As the Carrier Groups

Design, Synthesis and in Vitro Cytotoxicity of Novel Dinuclear Platinum(Ii) Complexes

Synthesis and in vitro Cytotoxicity of Platinum(Ⅱ) Complexes Chelated with Chiral N-monosubstituted 1,2-Cyclohexyldiamine Derivatives

Synthesis, Characterization and Biological Evaluation of Platinum(II) Complexes with a Chiral N-Monosubstituted 1,2-Cyclohexyldiamine Derivative

Synthesis, Cytotoxicity, and Apoptosis Induction Study of Antitumor Dinuclear Platinum(ii) Complexes.

In vitro cytotoxicity activity of platinum(II) complexes with alkyl-branched/cyclic alkoxyacetates as leaving ligands

Synthesis and Cytotoxic Evaluation of Novel Platinum(Ii) Complexes with C2-Asymmetric and C2-Symmetric Chiral Vicinal Diamines

Synthesis and antitumor activity of cis-platinum (II) type complexes containing alkoxylethoxylacetate groups

Novel antitumor dinuclear platinum (II) complexes with a new chiral tetradentate ligand as the carrier group

Novel Cisplatin-Type Platinum Complexes and Their Cytotoxic Activity

Synthesis and Biological Activity of Binuclear Platinum Complexes Containing Two Monofunctional Cis-[Pt(Nh3)(2)Cl](+) Units Bridged by 4,4 '-Dipyridyl Selenides or Sulfides

Synthesis, Cytotoxicity, Induction of Apoptosis, and Interaction with DNA of Dinuclear Platinum(II) Complexes

Synthesis and Antitumor Activity of Dinuclear Platinum Complexes with (1(i)R, 1(ii)R, 2(i)R, 2(ii)R)-N-i,N-ii-(1, 3-Phenylenebis(methylene))dicyclohexane-1, 2-diamie as the Ligand

Synthesis and Antitumor Activity of cis-Platinum(Ⅱ) Type Complexes Containing Alkoxylethoxylacetate Groups

Synthesis, invitro Cytotoxicity, and Interaction with DNA of Platinum(II) Complexes with N-Monocycloalkyl Derivatives of 1R,2R-Diaminocyclohexane as Carrier Ligands

Synthesis and in vitro antiproliferative activity of platinum(II) complexes with N-monoalkyl 1R,2R-diaminocyclohexane as ligands.

Synthesis and biological evaluation of water-soluble trans-[bicyclo[2.2.2]octane-7R,8R-diamine]platinum(II) complexes with linear or branched alkoxyacetates as leaving groups

Synthesis and Biological Evaluation of Platinum(ii) Complexes Containing (1R,2r)-N1-alkyl-1,2-diaminocyclohexane and D-(+)-camphorate Ligands